Shasha Jiao
Chinese Academy of Sciences
3 Papers
7 Citations
Shasha Jiao is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: MHC class I & Contig. The author has an hindex of 2, co-authored 2 publications. Previous affiliations of Shasha Jiao include Shihezi University.
Chat about Author
Papers
A physical map of a BAC clone contig covering the entire autosome insertion between ovine
Gang Li,Ka Liu,Shasha Jiao,Haibo Liu,Hugh T. Blair,Peng Zhang,Xiaoran Cui,Pingping Tan,Jianfeng Gao,Runlin Z. Ma +9 more
- 01 Jan 2012
TL;DR: The construction of a high-density physical map covering the ovine autosome insertion in order to address the question of what the inversion/insertion had to do with ruminants during the MHC evolution is reported.
8
A physical map of a BAC clone contig covering the entire autosome insertion between ovine MHC Class IIa and IIb.
Gang Li,Gang Li,Ka Liu,Shasha Jiao,Shasha Jiao,Haibo Liu,Hugh T. Blair,Peng Zhang,Xiaoran Cui,Pingping Tan,Jianfeng Gao,Jianfeng Gao,Runlin Z. Ma +12 more
TL;DR: In this article, the authors constructed a high-density BAC clone physical map covering the autosome insertion in order to address the question of what the inversion/insertion had to do with ruminants during the major histocompatibility complex (MHC) evolution.
Pre-Clinical Development of a Potent Neutralizing Antibody MW3321 With Extensive SARS-CoV-2 Variants Coverage
Wen Jiang,Zhe-Rui Zhang,Yuhe Zhu,Ben Chen,Chunying Gu,Zhiyan Liu,Xukai Zhang,Hualong Xiong,Ya-Nan Zhang,Bin Zheng,Rongjuan Wang,Shasha Jiao,An Wang,Jinchao Zhang,Shuang Wang,Bo Zhang,Gang Li,Xun Gui +17 more
TL;DR: Data support the development of MW3321 as a monotherapy or cocktail against SARS-CoV-2-related diseases and could effectively reduce viral burden in hACE2-transgenic mice challenged with either wild-type or Delta Sars-Cov-2 strains through viral neutralization and Fc-mediated effector functions.